Dr. Lisa Sudmeier, MD, PhD
Claim this profileClinical Trials Lisa Sudmeier, MD, PhD is currently running
More about Lisa Sudmeier, MD, PhD
Clinical Trial Related
1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Lisa Sudmeier, MD, PhD has experience with
- Arginine
- Whole Brain Radiation Therapy
Breakdown of trials Lisa Sudmeier, MD, PhD has run
Pancreatic Cancer
Brain Metastasis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lisa Sudmeier, MD, PhD specialize in?
Lisa Sudmeier, MD, PhD focuses on Pancreatic Cancer and Brain Tumor. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Lisa Sudmeier, MD, PhD currently recruiting for clinical trials?
Yes, Lisa Sudmeier, MD, PhD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Lisa Sudmeier, MD, PhD has studied deeply?
Yes, Lisa Sudmeier, MD, PhD has studied treatments such as Arginine, Whole Brain Radiation Therapy.
What is the best way to schedule an appointment with Lisa Sudmeier, MD, PhD?
Apply for one of the trials that Lisa Sudmeier, MD, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.